A Multicenter Prospective Study Evaluating Outcomes of Endoscopic Eradication Therapy in Patients With Barrett's Esophagus Associated Neoplasia: The TREAT-BE (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) Consortium
Status: Recruiting
Location: See all (4) locations...
Intervention Type: Procedure, Drug, Radiation
Study Type: Observational
SUMMARY
A prospective outcomes study in patients with and esophageal cancer (EAC) and Barrett's esophagus (BE) associated neoplasia being evaluated for endoscopic eradication therapy (EET).
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 100
Healthy Volunteers: t
View:
• Patients with Barrett's related neoplasia and dysplasia. Patients with esophageal cancer
Locations
United States
California
UCLA Medical Center
RECRUITING
Los Angeles
Florida
Moffitt Cancer Center
RECRUITING
Tampa
Illinois
Northwestern Memorial Hospital
RECRUITING
Chicago
Missouri
Washington University
RECRUITING
St Louis
Contact Information
Primary
Sachin Wani, MD
sachin.wani@ucdenver.edu
720-848-2786
Backup
Violette C Simon, MS
violette.simon@ucdenver.edu
303-724-6670
Time Frame
Start Date: 2015-01
Estimated Completion Date: 2027-01
Participants
Target number of participants: 5000
Treatments
Patients with Barrett's Esophagus
Patients with non-dysplastic Barrett's esophagus, patients with Barrett's related dysplasia which includes low-grade dysplasia, high-grade dysplasia and intramucosal cancer who will be evaluated and treated with endoscopic eradication therapies (EET).
Patients with invasive esophageal cancer
Patients with invasive esophageal cancer who will be treated with surgery (esophagectomy), chemotherapy, radiation, and palliative treatment modalities.
Related Therapeutic Areas
Sponsors
Collaborators: California Pacific Medical Center, Northwestern University Feinberg School of Medicine, H. Lee Moffitt Cancer Center and Research Institute, University of California, Los Angeles
Leads: University of Colorado, Denver